JCI Insight Review Time
JCI Insight is one of the more transparent clinical investigation journals on timing, but authors still need to distinguish between desk, reviewed, and transfer pathways.
While you wait
Waiting on a decision? Get your next move ready.
The wait is out of your hands; the next move isn't. Scan your next manuscript free, or run this paper through the scan to see what reviewers typically push back on, so the revision response is ready when the decision lands.
Use the last confirmed event while keeping the translational record ready
Journal-level timing cannot predict one manuscript; dated movement and author-side evidence preparation can guide the next proportionate action.
- 01Anchor
Record the submission, status transitions, correspondence, and author requests.
- 02Prepare
Reconcile mechanism, disease relevance, patient evidence, data, code, and reporting.
- 03Ask
Send one neutral inquiry only after a materially atypical interval.
Quick answer: JCI Insight review time is relatively fast by clinical-investigation standards, but the clock depends heavily on the manuscript route.
The journal has publicly reported an average time to decision of 21 days for reviewed manuscripts (per JCI Insight publisher guidelines).
Current SciRev data show about 1.1 months for the first review round, about 1.8 months total handling for accepted papers, and about 6 days for immediate rejection. Recent accepted-paper histories imply a more conservative accepted-paper range of about 113 to 132 days for standard cases.
Last reviewed: 2026-08-26.
Evidence basis: JCI Insight's current Author Information Center and first-submission instructions establish the submission and peer-review routes. Public article histories and third-party author reports are useful context, but they are not a promise about one manuscript. The action framework below is Manusights judgment, reviewed on 2026-08-26.
For full journal context, see the JCI Insight journal profile. Submissions are handled via the JCI Insight submission portal at insight.jci.org, and JCI Insight is published by the American Society for Clinical Investigation (ASCI publisher portal).
JCI Insight timing signals at a glance
The key point is that JCI Insight has several different clocks at once, and they should not be flattened into one number. A fast desk rejection, a rapid transfer decision from JCI, and a standard reviewed submission each run on a different timeline. The reviewed-manuscript figure the journal publishes is a useful anchor, but it does not describe the accepted-paper path, which is typically several months longer.
What the official sources do and do not tell you
JCI Insight is more transparent than many journals, but you need to read the signals carefully.
The official sources tell you:
- the journal has reported a 21-day average time to decision for reviewed manuscripts
- transferred papers previously reviewed at JCI generally receive a rapid decision in fewer than 7 days
- accepted research manuscripts are published shortly after acceptance as In-Press Previews unless authors opt out
- the journal is built to provide a respectful and timely review process
They do not tell you:
- a single current median for all manuscript routes combined
- how transfer-heavy or direct-submission-heavy a given current sample is
- whether a specific paper is more likely to follow the rapid-transfer lane or the slower standard-review lane
So the best planning model is to separate direct submissions, transfer decisions, and accepted-paper histories.
In our editorial analysis
The most useful author-side signal is not the age of one status label. It is the last confirmed event and whether the manuscript record is ready for the next likely request. Keep the mechanism, disease relevance, patient or model boundary, data and code record, reporting checklist, and author declarations synchronized while the journal evaluates the paper. This is Manusights judgment about preparation, not private JCI Insight workflow data.
A practical timeline authors can actually plan around
Stage | Practical expectation | What is happening |
|---|---|---|
Immediate desk no | Often under 1 week | Clear no-fit or no-priority papers can be filtered quickly |
Direct reviewed submission | Around 3 to 5 weeks to the first meaningful decision | This is where the 21-day journal note and 1.1-month SciRev number roughly overlap |
JCI transfer path | Often under 7 days for previously reviewed transfers | The journal can move very quickly when prior review already exists |
Revision and final acceptance | Several more weeks to months | The accepted path is longer than the first decision path |
Accepted-paper total path | Often about 3.5 to 4.5 months in public examples | Standard accepted cases are not just 21-day stories |
That is the real author model. JCI Insight can be fast, but not every paper is on the same route.
Concrete article-history examples
Recent article pages help anchor the longer accepted path.
Paper | Received | Accepted | Approx. elapsed time |
|---|---|---|---|
Neutrophil-targeted, protease-activated pulmonary drug delivery blocks airway and systemic inflammation | 2 Jul 2019 | 23 Oct 2019 | 113 days |
CDK1 inhibition reduces osteogenesis in endothelial cells in vascular calcification | 21 Sep 2023 | 19 Jan 2024 | 120 days |
Circulating immune biomarkers correlating with response in patients with metastatic renal cell carcinoma on immunotherapy | 16 Aug 2024 | 26 Dec 2024 | 132 days |
Those cases show why authors should not mistake the very fast first-decision signals for the whole accepted-paper cycle.
Why JCI Insight can feel fast
JCI Insight often feels fast because the editorial system was explicitly designed to be more respectful and efficient than many competing journals.
The journal can move quickly when:
- the paper is clearly a good JCI Insight fit
- the reviewers are already known through the JCI transfer route
- the requested revision is focused rather than sprawling
- the manuscript has strong clinical or translational value even if it is not a full JCI-level mechanism story
That is why the journal has built a reputation for author-friendlier handling.
What usually slows it down
The longer cases are usually the ones where the paper is good enough to keep moving, but still needs substantial improvement.
Common reasons include:
- direct submissions that do not benefit from prior JCI review
- revisions that require additional translational or mechanistic strengthening
- papers sitting between subspecialty-journal scope and broad clinical-investigation scope
- more complex cohort or methods issues than the abstract first suggests
That is why accepted papers can still land in the 3 to 4 month range even at a comparatively fast journal.
Desk timing and what to do while waiting
If the manuscript is at JCI Insight, the best use of the waiting period is to prepare for the route it is most likely on.
- if it is a JCI transfer, be ready to answer the existing review package quickly
- if it is a direct submission, tighten the clinical-investigation or translational case
- prepare concise, editor-friendly responses rather than sprawling rebuttals
- make sure the paper does not read like a specialty-journal study wearing a broader title
At JCI Insight, waiting well usually means preparing for a controlled revision rather than a dramatic rescue.
Timing context from the journal's editorial position
JCI Insight positions itself as an efficient, author-respectful venue, and the timing pattern fits that stated profile. But efficiency is not the same as leniency: the journal still expects papers to deserve its physician-scientist readership, so a fast process favors manuscripts whose translational fit is already clear at the desk. A borderline-fit paper does not get a faster answer here; it gets a longer revision cycle.
Longer-run journal trend and what it means for timing
For year-over-year citation metrics data, see the jci insight citation metrics page.
Year-over-year, JCI Insight is down from 8.0 in 2023 to 6.1 in 2024. The journal's operational identity still emphasizes respectful, timely review. Authors should read the timing story through that editorial model, not only through the citation number.
Readiness check
While you wait, scan your next manuscript.
The scan takes about 1-2 minutes. Use the result to decide whether to revise before the decision comes back.
What review-time data hides
Review-time discussions hide the most important distinction at JCI Insight:
- transfer papers can move much faster than direct submissions
- desk outcomes and reviewed outcomes are very different clocks
- accepted-paper timelines are longer than early editorial decisions
- the route into the journal matters as much as the quality of the paper itself
That is why one number is never enough here.
What we see in JCI Insight manuscripts
The most common timing mistake is assuming that because the journal is faster than many peers, a borderline-fit paper is worth trying just to get a quick answer.
That still wastes time.
The papers that move best here usually have:
- clear clinical or translational relevance on page one
- enough depth to matter without pretending to be full JCI-level mechanism work
- a straightforward narrative for physician-scientist readers
- fewer obvious questions about whether a narrower specialty journal owns the story
Those traits improve timing because they make editorial routing much easier.
What pre-submission reviews reveal
For JCI Insight-targeted manuscripts, three patterns most consistently predict slow review at JCI Insight (American Society for Clinical Investigation). A recurring failure pattern in manuscripts in 2025 targeting JCI Insight and peer venues, the patterns below are the same ones our reviewers flag in real time. The named editorial-culture quirk: JCI Insight reviewers expect both mechanistic depth and translational implications; mechanism-only or clinical-only papers extend revision.
Scope-fit ambiguity in the abstract. JCI Insight editors move fastest on manuscripts whose contribution is obviously aligned with the journal's editorial scope (translational research). The named failure pattern: mechanism-only papers without translational-implication framing extend revision rounds. Check whether your abstract reads to JCI Insight's scope →
Methods package incomplete for the journal's reviewer pool. JCI Insight reviewers expect specific methodological detail. Clinical observational studies without mechanistic underpinning extend reviewer consultation. Check if your methods package is reviewer-complete →
Reference-list and clean-citation failure mode. Editorial team at JCI Insight (American Society for Clinical Investigation) screens reference lists for retracted-paper inclusion. Check whether your reference list is clean against Crossref + Retraction Watch →
Editorial detail (for desk-screen calibration). Verify the current Editor-in-Chief and handling-editor list on the journal's editorial-team page before quoting any name in a submission cover letter. Submission portal: Insight journal page. Manuscript constraints: 200-word abstract limit and 9,000-word main-text cap (JCI Insight enforces during desk-screen).
We reviewed each constraint against the current journal author guidance. The planning ranges and action thresholds are bounded editorial interpretation, not a private journal dataset or a prediction for one manuscript.
Editorial risk signal for JCI Insight (American Society for Clinical Investigation). A recurring failure pattern in manuscripts before submission to JCI Insight and peer venues in 2025, the editorial-culture mismatch most consistent across the cohort is JCI Insight reviewers expect both mechanistic depth and translational implications; mechanism-only or clinical-only papers extend revision.
A cautious planning model for JCI Insight-targeted submissions, the documented review timeline shows a bimodal distribution between manuscripts that clear JCI Insight's scope-fit threshold within the first week and those that get extended editorial-board consultation. Top-line triage is handled by the journal's editorial team; verify the current handling editor on the journal's editorial-team page before quoting any name in a cover letter.
Submit If
- The headline finding fits JCI Insight (American Society for Clinical Investigation)'s editorial scope (translational research) and the abstract names that fit within the first 100 words for JCI Insight's editorial-team triage.
- The methods section is detailed enough for JCI Insight reviewers to evaluate without follow-up; protocol and reproducibility detail are in the main text rather than deferred to supplementary materials.
- The reference list is clean of recently retracted citations.
- A figure or table makes the contribution visible without specialist translation; the cover letter explicitly names the JCI Insight-relevant audience the work is aimed at.
Think Twice If
- Mechanism-only papers without translational-implication framing extend revision rounds; this is the named JCI Insight desk-screen failure mode our team flags before submission.
- The cover letter spends a paragraph on background before the new finding appears in the abstract; JCI Insight's editorial culture treats this as a scope-fit warning.
- The reference list cites a paper that has since been retracted without acknowledging the retraction notice.
- The protocol or methodology section relies on more than 3 figures of supplementary material that should be in the main text for JCI Insight's reviewer pool.
What should drive the submission decision instead
For JCI Insight, speed matters, but route and editorial fit matter more.
That is why the better next reads are:
- JCI Insight citation metrics
A JCI Insight fit check is usually more valuable than focusing on the fastest-path anecdotes.
Practical verdict
JCI Insight review time is relatively fast for a clinical investigation journal, but the journal really has multiple timelines. Fast desk outcomes, rapid JCI transfers, and standard reviewed submissions should not be confused with one another. For many normal accepted papers, the realistic planning range is still around 3.5 to 4.5 months.
The Manusights JCI Insight readiness scan. This guide tells you what JCI Insight (American Society for Clinical Investigation)'s editors look for in the first 1-2 weeks of triage. The review tells you whether your paper passes that check before you submit.
We have reviewed manuscripts targeting JCI Insight (American Society for Clinical Investigation) and peer venues; the named patterns below are the same ones the journal's handling editors and outside reviewers flag at the desk-screen and first-review stages. documented review timeline of approximately 7-10 days for desk-screen. 60-day money-back guarantee. Your manuscript is not used for model training, and access is limited to the review workflow.
Frequently asked questions
JCI Insight has unusually useful public timing signals. An editorial note from the journal reported an average time to decision of 21 days for reviewed manuscripts, and current SciRev data show about 1.1 months for the first review round and about 1.8 months total handling for accepted papers.
SciRev reports about 6 days for immediate rejection, and JCI Insight says transferred papers previously reviewed at JCI generally receive a rapid decision in fewer than 7 days.
Recent article histories show accepted-paper paths of about 113 to 132 days in several examples. That suggests a realistic accepted-paper path of roughly 3.5 to 4.5 months for many papers that go through normal review rather than a fast transfer route.
The route into the journal matters most. Direct submissions, transferred manuscripts from JCI, and obvious desk outcomes can move on very different clocks.
Free guide
Waiting is not the same as being ignored, and there is a way to tell.
Reviewers usually get ten days. When it has been months, an appeal and a complaint are different instruments with different addresses, and only one of them fits a delay. This is which to use, and the wording that gets an answer.
Final step
Done interpreting the status? Put the wait to work.
The decision will arrive on the journal's clock. What you control is what's next: scan your next manuscript free, or run this paper through the scan so the likely reviewer pushback is mapped before the revision request lands.
Free scan, no card needed.
Private API processing. Your manuscript is not used to train models.
Re-read the status guidePut the guidance to work
Turn a decision into a clear next step.
Use the practical response workflow when a manuscript needs revision, or the process guide when you need to understand what the editorial status means.
Where to go next
Same journal, next question
- JCI Insight 'Under Review': What Each Status Means and When to Expect a Decision
- JCI Insight Submission Process: What Happens After You Upload
- How to Avoid Desk Rejection at JCI Insight (2026)
- JCI Insight Acceptance Rate (2026): What the ~30% Number Actually Means
- JCI Insight Impact Factor 2026: 6.8, Q1
- JCI Insight Response to Reviewers: A Translational Revision Guide